Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials.
about
Urinary tract infection in the setting of vesicoureteral refluxGlobal prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysisNovel Strategies in the Prevention and Treatment of Urinary Tract InfectionsAntibiotic prophylaxis and reflux: critical review and assessmentFrom in vitro to in vivo Models of Bacterial Biofilm-Related Infections.Escherichia coli biofilm formation and recurrences of urinary tract infections in children.Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study.Medical versus surgical management for vesicoureteric reflux: the case for medical management.A guideline for the inpatient care of children with pyelonephritisDiagnosis and management of urinary tract infection in children.Home screening for bacteriuria in children with spina bifida and clean intermittent catheterization.Risk factors for renal scarring and deterioration of renal function in primary vesico-ureteral reflux children: a long-term follow-up retrospective cohort study.Treatment and prophylaxis in pediatric urinary tract infectionVesicoureteral reflux, reflux nephropathy, and end-stage renal disease.National ambulatory antibiotic prescribing patterns for pediatric urinary tract infection, 1998-2007.Controversies in the management of vesicoureteral reflux: the rationale for the RIVUR studyManaging urinary tract infections.Management trends in prenatally detected hydronephrosis: national survey of pediatrician practice patterns and antibiotic useSubinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunityRisk Factors for Recurrent Urinary Tract Infection and Renal Scarring.Evaluation of the Bladder Stimulation Technique to Collect Midstream Urine in Infants in a Pediatric Emergency Department.Characteristics and Antibiotic Resistance of Urinary Tract Pathogens Isolated From Punjab, PakistanLoss of MeCP2 Causes Urological Dysfunction and Contributes to Death by Kidney Failure in Mouse Models of Rett Syndrome.Evaluation of new American Academy of Pediatrics guideline for febrile urinary tract infection.The influence of antibiotic prophylaxis on bacterial resistance in urinary tract infections in children with spina bifida.Intracellular bacteria in the pathogenesis of Escherichia coli urinary tract infection in children.The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infectionsIncidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota.Comparative effectiveness research using the electronic medical record: an emerging area of investigation in pediatric primary careIndividualizing management of vesicoureteral reflux.The outcome of surgery versus medical management in the treatment of vesicoureteral reflux.Antibiotic prophylaxis for children with primary vesicoureteral reflux: where do we stand today?Diagnostic approach to reflux in 2007Incidence of Urinary Tract Infection Among Siblings of Children With Vesicoureteral Reflux.Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.Persistence of Escherichia coli clones and phenotypic and genotypic antibiotic resistance in recurrent urinary tract infections in childhood.Antibiotic prophylaxis in pediatric urology.The current evidence based medical management of vesicoureteral reflux: The Sickkids protocol.Are prophylactic antibiotics indicated after a urinary tract infection?Health insurance and length of stay for children hospitalized with community-acquired pneumonia.
P2860
Q26740621-9D64C620-5B65-4E2E-A360-E66161A3DDDCQ26765378-D4D407FC-EB62-44C6-A563-60CFCF65FA34Q26772924-9DEEF6F1-C764-4753-9FE2-EE983A06F73FQ26851346-327D35B5-0E1D-4809-AA97-B65B6F0D2202Q30424697-D7E5157A-B8DB-41D1-8F94-EAFA3D4FB49EQ31135716-69D2B979-CDE8-4DC8-8173-D2D5D7290407Q33741119-EBB28B25-EA55-4414-AAE8-5452EF5995EAQ34023061-20E79573-4201-451C-A6FB-C63C08220A5CQ34136077-26DFBDDE-61EF-4DD2-A6CE-47ABF8C425FCQ34157226-18C8B022-A940-4D1F-BC59-863FC3182736Q34452596-49620900-3652-454D-9C3D-6B87CBD37965Q34612691-9C108F76-39C2-4BDD-A746-60CB7FEDB84BQ34714160-02189301-8C67-4E45-93D2-332BEF6A9E13Q34803138-0FE98ED3-B16B-4D65-B310-239D98C6E466Q35010735-EDEFB778-2679-4F70-993E-573BACCCD92CQ35184683-39D21304-EDB8-411D-933F-02EA2BD6E69CQ35226372-285505C9-CDA8-4C3F-B09B-3B6068186373Q35249263-82796982-217A-4F19-AE26-C297317EEAF1Q35677483-C6F83348-9B5F-436A-B561-BD235991D52DQ35795726-020D51A0-4597-4F19-B244-8832B49CA894Q35975529-8ACDCA23-124C-4290-A5A6-7A908C8D20C6Q36095704-DBBB0D16-4080-435F-AED0-CC00F3DCDACCQ36187325-4404FA1A-6625-475A-A06A-063858797F6CQ36216147-1A539B2B-DEF2-4D0B-8D29-EFB7B3DD2E77Q36248081-C934E23B-F8E4-416C-8EE9-BAF6AED70FB3Q36293989-59F11CB3-ADD2-4E1C-9478-C3B33D883D30Q36299210-DE3B42C4-A31A-42F9-A2AC-1590A74451D3Q36513085-4403621C-A610-4264-91FB-DBD5B722D2C1Q36651625-B4784DD9-505E-417D-85ED-609C51F9CB13Q36734378-7514B4E4-50CD-413F-A4A1-8ECBB896C17BQ36784138-7DC7B147-A57B-4DBE-B716-5C98A0EF0473Q36807362-F538F948-9813-4FE4-9AAF-10FA28A4A133Q36853660-6361411B-B940-4DDD-A1F2-30C8A5BE48F6Q36901600-0EFA396C-C10D-43AA-B141-856794618B31Q36910650-01C5E3B6-8C09-4CF4-9111-CD3909FE930DQ37051521-B2A71533-5CC2-489F-817B-207AF30498BAQ37197562-569ABB48-84FC-47A8-90DC-0CC5A1F38DC8Q37291151-0244D7FA-140F-437F-93D8-48523B489D22Q37301440-FBCD8871-88BF-4117-BA75-6D0C77D35502Q37425074-3D7A99CA-FF43-44AA-BE0D-AD4D3B787B2C
P2860
Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Recurrent urinary tract infect ...... h prophylactic antimicrobials.
@en
Recurrent urinary tract infect ...... h prophylactic antimicrobials.
@nl
type
label
Recurrent urinary tract infect ...... h prophylactic antimicrobials.
@en
Recurrent urinary tract infect ...... h prophylactic antimicrobials.
@nl
prefLabel
Recurrent urinary tract infect ...... h prophylactic antimicrobials.
@en
Recurrent urinary tract infect ...... h prophylactic antimicrobials.
@nl
P2093
P356
P1476
Recurrent urinary tract infect ...... h prophylactic antimicrobials.
@en
P2093
Avital Cnaan
Brandon V Henry
Patrick H Conway
Robert W Grundmeier
Theoklis Zaoutis
P304
P356
10.1001/JAMA.298.2.179
P407
P577
2007-07-01T00:00:00Z